Latest Strategic Partnerships News

Cogstate Limited has reported a landmark FY25 with revenue up 22% and net profit before tax nearly doubling, driven by a surge in clinical trials contracts and strategic innovation. The company also declared its maiden fully franked dividend and outlined ambitious growth plans including AI product launches and an expanding Medidata partnership.

BrainChip Holdings reports a significant revenue surge and reduced losses in H1 2025, underpinned by new contracts, strategic collaborations, and an expanded funding agreement.

Wrkr Ltd reported a 10.8% revenue increase to $10.63 million and narrowed its net loss to $2.62 million for FY2025, while securing $15 million in fresh capital to accelerate growth amid upcoming PayDay Super reforms.

Atomo Diagnostics reports a significant expansion in its supply agreement with Lumos for the Pascal test cassette, tied to the promising CLIA waiver status of the FebriDx test in the US. This deal could nearly double Atomo’s revenues over the next three years.

RooLife Group Ltd (ASX, RLG) has launched its proprietary RLG Coffee brand in China, tapping into a rapidly expanding market with early sales exceeding $110,000 in the first month. Strategic partnerships and a recent supply deal position RLG for broader growth in the country’s evolving consumer landscape.

Tinybeans Group Ltd reported a significant reduction in losses and a 12% rise in subscription revenue for FY25, driven by a strategic pivot away from advertising. The company’s restructuring efforts have improved cash flow and positioned it for sustainable growth.

NAOS Ex-50 Opportunities Company Limited (ASX, NAC) reported a strong turnaround with a $7.55 million profit after tax for FY25 and a 28.9% portfolio return, declaring a 1.5 cent per share dividend. The company’s focused investments in emerging Australian and New Zealand companies underpin its robust performance and disciplined capital management.

Artrya Limited has secured FDA 510(k) clearance for its Salix Coronary Plaque module, enabling near real-time detection of high-risk coronary artery plaque and opening a lucrative U.S. market opportunity with a $950 reimbursement per scan.

Lark Distilling Co. Ltd reported a 3% revenue increase to $17.17 million for FY25, driven by whisky sales growth and a major brand restage, while losses widened significantly due to increased marketing spend and operational investments.

Li-S Energy Limited reported a $6.41 million net loss for FY25 while making significant strides in commercialising its lithium-sulfur battery technology, including commissioning new production facilities and securing key strategic partnerships.

Turners Automotive Group has reported a record FY25 financial performance, with net profit after tax rising 17% to $38.6 million and dividends increasing 14% to 29.0 cents per share, underscoring resilience amid a challenging New Zealand economy.

Alliance Aviation Services reported record flying hours and strong revenue growth in FY25, while statutory profit dipped slightly amid operational challenges.